Generated August 5, 2026 at 8:32 PM ET
· Covers August 5 trading day
· 9 of 581 ready 8-Ks selected
· AI-assisted overview
Gran Tierra Energy sells its Colombia and Ecuador assets for $1.33B and expects to become debt-free. Martin Marietta Materials receives all regulatory approvals for its $13.5B acquisition of Lhoist North America, with a Q3 2026 close expected. Axalta Coating Systems shareholders approve its all-stock merger with AkzoNobel. CoreCivic reports Q2 adjusted EPS of $0.38, sells four detention facilities for $2.2B, and expands its share buyback by $500M. Pacific Biosciences reports Q2 revenue of $39M and a net loss of $44.7M, with CEO Henry stepping down and a restructuring cutting 8% of the workforce. Upland Software receives a Nasdaq deficiency notice for failing the $15M minimum market value of publicly held shares, while Vistagen and Destination XL each receive extensions to cure bid price deficiencies.
UPLD
Upland Software, Inc.
regulatory
negative
materiality 0.75
August 5, 2026, 4:40 PM ET
Upland Software receives Nasdaq deficiency notice for failing $15M MVPHS requirement
- Received notice on July 31, 2026 for non-compliance with Nasdaq's $15M minimum market value of publicly held shares.
- Has 180 days, until January 27, 2027, to regain compliance with the MVPHS requirement.
- If not regained, Nasdaq will issue a delisting notice; company may appeal to a Nasdaq Hearings Panel.
GTE
GRAN TIERRA ENERGY INC.
M&A
positive
materiality 1.00
August 5, 2026, 7:06 AM ET
Gran Tierra sells Colombia/Ecuador assets to Maurel & Prom for $1.33B; to become debt-free
- Total consideration of $1.33B includes assumption of debt and prepayment facility; net cash proceeds ~$315M.
- Company expects ~$250M cash at close, zero debt, and a $65M note receivable due in 364 days.
- Continuing company pro-forma PDP NAV (NPV10 BT) ~$12.49/share, an 83% premium to 20-day VWAP.
MLM
MARTIN MARIETTA MATERIALS INC
M&A
positive
materiality 0.85
August 5, 2026, 5:14 PM ET
Martin Marietta receives all regulatory approvals for $13.5B Lhoist North America acquisition; Q3 2026 close expected
- Received all necessary regulatory approvals for $13.5B acquisition of Lhoist North America (LNA).
- Transaction expected to close in Q3 2026, subject to customary closing conditions.
- Deal announced June 27, 2026; consideration is cash and Martin Marietta common stock.
AXTA
Axalta Coating Systems Ltd.
M&A
positive
materiality 0.85
August 5, 2026, 5:10 PM ET
Axalta shareholders approve all-stock merger of equals with AkzoNobel
- Merger proposal approved by 83.45% of shares entitled to vote (99.97% of votes cast).
- AkzoNobel shareholders also approved the merger at their Extraordinary General Meeting.
- Completion expected late 2026 to early 2027, subject to regulatory approvals and conditions.
VTGN
Vistagen Therapeutics, Inc.
regulatory
negative
materiality 0.70
August 5, 2026, 4:04 PM ET
Vistagen gets Nasdaq extension to Feb 1, 2027 to cure $1.00 bid price deficiency
- Received 180-day extension until February 1, 2027 to regain compliance with Nasdaq minimum bid price of $1.00.
- Previously disclosed non-compliance on February 6, 2026; has not yet cured the deficiency.
- If not compliant by end of Extension Period, Nasdaq will issue delisting notice; company may appeal.
DXLG
DESTINATION XL GROUP, INC.
regulatory
negative
materiality 0.65
August 5, 2026, 5:06 PM ET
DXLG gets Nasdaq approval to transfer to Capital Market; gains 180-day extension to cure bid price deficiency
- Transfer to Nasdaq Capital Market effective August 7, 2026; stock continues trading under DXLG.
- Additional 180-day compliance period until February 1, 2027 to regain $1.00 minimum bid price.
- Company may consider a reverse stock split to cure deficiency if needed.
litigation
positive
materiality 0.70
August 5, 2026, 4:40 PM ET
Spire Global wins $12.4M arbitration award against NorthStar; all claims dismissed
- Arbitral tribunal awarded Spire ~$12.4M, dismissing NorthStar's $45.9M claims for breach and fraud.
- Tribunal granted Spire's counterclaims on $4.5M promissory note and arbitration costs.
- Award is final and binding; payment immediately due from NorthStar.
earnings
positive
materiality 0.90
August 5, 2026, 4:04 PM ET
CoreCivic Q2 adj. EPS $0.38 beats; sells 4 facilities for $2.2B; expands buyback by $500M
- Q2 revenue $684.9M (+27.3% YoY); adj. diluted EPS $0.38 (+5.6% YoY); occupancy 78.4% vs 76.8%.
- Sold four detention facilities to U.S. government for $2.2B gross; gain on sale ~$1.8B; net proceeds ~$1.6B.
- Board authorized additional $500M share repurchase, increasing total authorization to $1.2B; $755.8M remaining.
PACB
PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
earnings
negative
materiality 0.85
August 5, 2026, 4:23 PM ET
PacBio Q2 revenue $39M, net loss $44.7M; CEO Henry steps down, Van Oene appointed; restructuring cuts 8% workforce
- Q2 revenue $39.0M (down 2% YoY); GAAP net loss $44.7M ($0.14 loss per share); non-GAAP net loss $41.9M.
- Revio placements 20, Vega placements 26; consumable revenue $20.1M; annualized Revio pull-through ~$202K.
- Full-year 2026 revenue guidance $155-165M; commenced SPRQ-Nx chemistry rollout at $345/genome.